Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
GAMCO INVESTORS, INC. ET AL CUTR Cutera, Inc. 13D/A 3.5% 2y
STILWELL JOSEPH PVBC Provident Bancorp, Inc. (MD) Common Stock 13D/A 10.4% 2y
Bertelsmann SE & Co. KGaA AFYA Afya Ltd 13D/A 61.3% 2y
CPMG Inc PRCT PROCEPT BioRobotics Corp 13D/A 3.4% 2y
Joseph Reda GWAV Greenwave Technology Solutions, Inc. 13G/A 6.25% 2y
Madryn Asset Management, LP GBNH Greenbrook TMS Inc. Common Shares 13D/A 61% 2y
Saba Capital Management, L.P. CXE Mfs High Income Municipal Trust 13D/A 8.44% 2y
ORBIMED ADVISORS LLC APLM Apollomics Inc. 13D/A 7.9% 2y
Stewart W. Bainum, Jr (“Mr. Bainum, Jr.” or the “Reporting Person”) CHH Choice Hotels International Inc 13D/A 19.94% 2y
Temasek Holdings (Private) Ltd CHRS Coherus Oncology, Inc. 13G/A 5.4% 2y
Green Equity Investors VI, L.P. SIG Signet Jewelers Ltd 13D/A 1.3% 2y
OAK HILL ADVISORS LP XPRO Expro Ltd 13D/A 11% 2y
Institutional Venture Management XVI, LLC HIMS Hims & Hers Health, Inc. 13D/A 3.6% 2y
Casdin Capital, LLC LAB Standard Biotools Inc. 13D/A 20.37% 2y
TingTing Jiang DOGZ Dogness (International) Corp 13G 5.46% 2y
Yuzhang Zhou DOGZ Dogness (International) Corp 13G 13.66% 2y
Mi Zhang DOGZ Dogness (International) Corp 13G 5.46% 2y
Xuzhong Xu DOGZ Dogness (International) Corp 13G 13.66% 2y
Yuhua Lin DOGZ Dogness (International) Corp 13G 16.39% 2y
Adiumentum Capital Fund I LP ATRA Atara Biotherapeutics, Inc. 13D 6.7% 2y
F. Hurst Lin (“Lin”) GCT GigaCloud Technology Inc 13D/A 16.9% 2y
GKCC, LLC INKT MiNK Therapeutics, Inc. 13G 11.79% 2y
JANUS HENDERSON GROUP PLC CTMX CytomX Therapeutics, Inc. 13G 5.3% 2y
WOLVERINE ASSET MANAGEMENT LLC AQUC Aquaron Acquisition Corp. 13G/A 0% 2y
WOLVERINE ASSET MANAGEMENT LLC GAQ Generation Asia I Acquisition Limited Class A Ordinary Shares 13G/A 3.14% 2y
WOLVERINE ASSET MANAGEMENT LLC HUDA Hudson Acquisition I Corp. Common Stock 13G/A 0% 2y
Al Shams Investments LTD BHR Braemar Hotels & Resorts Inc. 13D 9.8% 2y
Al Shams Investments Limited BHR Braemar Hotels & Resorts Inc. 13D 9.8% 2y
Point72 Asset Management, L.P. RPD Rapid7, Inc. 13G 5% 2y
Blackstone Inc. AUTL Autolus Therapeutics plc 13D/A 8.8% 2y
Magnetar Financial LLC SP SP Plus Corporation 13D/A 0% 2y
Luis Dussan LIDR AEye, Inc. 13D/A 5.16% 2y
Saba Capital Management, L.P. BMEZ BlackRock Health Sciences Term Trust 13D/A 19.1% 2y
Saba Capital Management, L.P. ECAT BlackRock ESG Capital Allocation Term Trust 13D/A 28.02% 2y
Saba Capital Management, L.P. BCAT BlackRock Capital Allocation Term Trust 13D/A 15.2% 2y
Saba Capital Management, L.P. BSTZ BlackRock Science & Technology Term Trust 13D/A 8.59% 2y
Saba Capital Management, L.P. MYN Blackrock Muniyield New York Quality Fund, Inc. 13D/A 5.75% 2y
Saba Capital Management, L.P. BTX BlackRock Technology & Private Equity Term Trust 13D/A 23.22% 2y
Saba Capital Management, L.P. MPA Blackrock Muniyield Pennsylvania Quality Fund 13D/A 17.13% 2y
BOSTON OMAHA Corp SKYH Sky Harbour Group Corp 13D/A 63.1% 2y
BCM Investimentos Fundo de Investimento Multimercado Crédito Privado Investimento no Exterior CLVR Clever Leaves Holdings Inc. Common Shares 13D/A 18.36% 2y
Bpifrance Participations S.A. CLLS Cellectis S.A. 13D/A 6.9% 2y
INVESTOR AB ERIC Ericsson Lm Telephone Co 13D 5.6% 2y
ROBOTTI ROBERT TDW Tidewater Inc 13D/A 4.7% 2y
Jeffrey Wolf SCPX Scorpius Holdings, Inc. 13D/A 9.6% 2y
Pertento Partners LLP CRAI Cra International, Inc. 13G 5.1% 2y
BML Investment Partners, L.P. OKUR OnKure Therapeutics, Inc. 13G/A 11% 2y
MILLENNIUM MANAGEMENT LLC MGNX Macrogenics Inc 13G 4.3% 2y
FIG LLC BRST Broad Street Realty, Inc. 13D 6.9% 2y
Ramaswamy Vivek BZFD BuzzFeed, Inc. 13D 7.7% 2y